Invitae Investor Relations Material
Latest events
Q3 2023
Invitae
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Invitae Corporation
Access all reports
Segment Data
Access more data
Revenue by
Source
Test revenue
Other
Expenses by
Financials
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people. The company offers clinical and genetic testing services to evaluate the risk of inherited conditions. It also provides diagnostic products and services, including laboratory developed tests and other diagnostic reagents to physicians and hospitals. The company offers hereditary cancer testing services under the Vectra 360 brand, prenatal testing services under the Angelica brand, and germline gene mutation screening under the Genomind brand. The company is based in San Francisco, California.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
NVTA
Country
🇺🇸 United States